180 related articles for article (PubMed ID: 9055350)
1. Effects of talipexole on emesis-related changes in abdominal afferent vagal activity and ileal serotonin metabolism in rats.
Minami M; Nemoto M; Endo T; Hamaue N; Kohno Y
Res Commun Mol Pathol Pharmacol; 1997 Jan; 95(1):67-82. PubMed ID: 9055350
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of talipexole and bromocriptine on serotonin release from rat intestinal tissues--an in vitro study of the emetic response of antiparkinsonian dopamine agonists.
Minami M; Kohno Y; Endo T; Nemoto M; Ogawa T; Ihira E; Hamaue N; Hirafuji M
Res Commun Mol Pathol Pharmacol; 1999; 104(1):3-12. PubMed ID: 10604273
[TBL] [Abstract][Full Text] [Related]
3. Effects of granisetron, a selective 5-HT3 receptor antagonist, on ouabain-induced emesis in ferrets.
Endo T; Sugawara J; Nemoto M; Minami M; Blower PR
Res Commun Mol Pathol Pharmacol; 1998 Dec; 102(3):227-39. PubMed ID: 10342910
[TBL] [Abstract][Full Text] [Related]
4. Bromocriptine, a dopamine D(2) receptor agonist with the structure of the amino acid ergot alkaloids, induces neurite outgrowth in PC12 cells.
Oda T; Kume T; Izumi Y; Takada-Takatori Y; Niidome T; Akaike A
Eur J Pharmacol; 2008 Nov; 598(1-3):27-31. PubMed ID: 18835264
[TBL] [Abstract][Full Text] [Related]
5. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
Bartoszyk GD; Harting J; Minck KO
J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
[TBL] [Abstract][Full Text] [Related]
6. Action of intravenously administered talipexole on the rat striatal neurons receiving excitatory input from nigral dopamine neurons.
Matsubayashi H; Amano T; Hongjing Y; Kohno Y; Sasa M
Psychopharmacology (Berl); 1995 Aug; 120(4):369-75. PubMed ID: 8539316
[TBL] [Abstract][Full Text] [Related]
7. Anti-tremor activity of talipexole produced by selective dopamine D2 receptor stimulation in cynomolgus monkeys with unilateral lesions in the ventromedial tegmentum.
Kohno Y; Fukuzaki K; Kitahara K; Koja T
Eur J Pharmacol; 1997 Jan; 319(2-3):197-205. PubMed ID: 9042591
[TBL] [Abstract][Full Text] [Related]
8. 5-HT activates vagal afferent cell bodies in vivo: role of 5-HT2 and 5-HT3 receptors.
Lacolley P; Owen JR; Sandock K; Lewis TH; Bates JN; Robertson TP; Lewis SJ
Neuroscience; 2006 Nov; 143(1):273-87. PubMed ID: 17029799
[TBL] [Abstract][Full Text] [Related]
9. Activation of cholecystokinin (CCK 1) and serotonin (5-HT 3) receptors increases the discharge of pancreatic vagal afferents.
Mussa BM; Sartor DM; Verberne AJ
Eur J Pharmacol; 2008 Dec; 601(1-3):198-206. PubMed ID: 19026634
[TBL] [Abstract][Full Text] [Related]
10. Effects of talipexole on motor behavior in normal and MPTP-treated common marmosets.
Irifune M; Nomoto M; Fukuda T
Eur J Pharmacol; 1993 Jul; 238(2-3):235-40. PubMed ID: 8104807
[TBL] [Abstract][Full Text] [Related]
11. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
[TBL] [Abstract][Full Text] [Related]
12. 5-Hydroxytryptamine (5-HT)-induced depolarization in isolated abdominal vagus nerves in the rat: involvement of 5-HT3 and 5-HT4 receptors.
Nemoto M; Endo T; Minami M; Yoshioka M; Ito H; Saito H
Res Commun Mol Pathol Pharmacol; 2001; 109(3-4):217-30. PubMed ID: 11758651
[TBL] [Abstract][Full Text] [Related]
13. Effects of granisetron, a 5-HT3 receptor antagonist, on 5-hydroxytryptamine (5-HT) release from the isolated ileum in a delayed-emesis rat model.
Endo T; Hamaue N; Ihira E; Teramoto Y; Liu Y; Hirafuji M; Minami M
Res Commun Mol Pathol Pharmacol; 2002; 111(1-4):55-68. PubMed ID: 14632314
[TBL] [Abstract][Full Text] [Related]
14. [Ventilatory mechanical analysis of respiratory depression induced by serotonin].
Goda Y
Hokkaido Igaku Zasshi; 1993 Jan; 68(1):29-41. PubMed ID: 8444402
[TBL] [Abstract][Full Text] [Related]
15. Postsynaptic 5-HT(1A) receptors mediate an increase in locomotor activity in the monoamine-depleted rat.
Mignon L; Wolf WA
Psychopharmacology (Berl); 2002 Aug; 163(1):85-94. PubMed ID: 12185404
[TBL] [Abstract][Full Text] [Related]
16. Central bromocriptine-induced tachycardia is reversed to bradycardia in conscious, deoxycorticosterone acetate-salt hypertensive rats.
Lahlou S
Pharmacol Toxicol; 2001 May; 88(5):238-43. PubMed ID: 11393583
[TBL] [Abstract][Full Text] [Related]
17. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
Capasso A; Sorrentino L
Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic analyses, based on dopamine D2-receptor occupancy of bromocriptine, of bromocriptine-induced contralateral rotations in unilaterally 6-OHDA-lesioned rats.
Atsumi M; Kawakami J; Sugiyama E; Kotaki H; Sawada Y; Sato H; Yamada Y; Iga T
Synapse; 2003 Nov; 50(2):110-6. PubMed ID: 12923813
[TBL] [Abstract][Full Text] [Related]
19. Ergoline derivative LEK-8829-induced turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine.
Sprah L; Zivin M; Sket D
J Pharmacol Exp Ther; 1999 Mar; 288(3):1093-100. PubMed ID: 10027846
[TBL] [Abstract][Full Text] [Related]
20. 5-HT3 receptor blocking properties of the antiparkinsonian agent, talipexole.
Nishio H; Kohno Y; Fujii A; Negishi Y; Inoue A; Nakata Y
Gen Pharmacol; 1996 Jul; 27(5):779-85. PubMed ID: 8842679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
